1. Home
  2. RVLV vs PTGX Comparison

RVLV vs PTGX Comparison

Compare RVLV & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVLV
  • PTGX
  • Stock Information
  • Founded
  • RVLV 2003
  • PTGX 2006
  • Country
  • RVLV United States
  • PTGX United States
  • Employees
  • RVLV N/A
  • PTGX N/A
  • Industry
  • RVLV Catalog/Specialty Distribution
  • PTGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVLV Consumer Discretionary
  • PTGX Health Care
  • Exchange
  • RVLV Nasdaq
  • PTGX Nasdaq
  • Market Cap
  • RVLV 2.6B
  • PTGX 2.7B
  • IPO Year
  • RVLV 2019
  • PTGX 2016
  • Fundamental
  • Price
  • RVLV $30.01
  • PTGX $36.82
  • Analyst Decision
  • RVLV Buy
  • PTGX Strong Buy
  • Analyst Count
  • RVLV 14
  • PTGX 8
  • Target Price
  • RVLV $28.89
  • PTGX $54.63
  • AVG Volume (30 Days)
  • RVLV 1.0M
  • PTGX 660.4K
  • Earning Date
  • RVLV 02-25-2025
  • PTGX 02-25-2025
  • Dividend Yield
  • RVLV N/A
  • PTGX N/A
  • EPS Growth
  • RVLV 29.44
  • PTGX N/A
  • EPS
  • RVLV 0.57
  • PTGX 2.68
  • Revenue
  • RVLV $1,093,961,000.00
  • PTGX $323,795,000.00
  • Revenue This Year
  • RVLV $6.76
  • PTGX $441.08
  • Revenue Next Year
  • RVLV $8.68
  • PTGX N/A
  • P/E Ratio
  • RVLV $52.59
  • PTGX $13.72
  • Revenue Growth
  • RVLV 2.23
  • PTGX 125.73
  • 52 Week Low
  • RVLV $13.96
  • PTGX $23.89
  • 52 Week High
  • RVLV $39.58
  • PTGX $48.89
  • Technical
  • Relative Strength Index (RSI)
  • RVLV 39.11
  • PTGX 39.62
  • Support Level
  • RVLV $28.14
  • PTGX $35.03
  • Resistance Level
  • RVLV $29.96
  • PTGX $40.07
  • Average True Range (ATR)
  • RVLV 1.40
  • PTGX 1.56
  • MACD
  • RVLV -0.36
  • PTGX -0.04
  • Stochastic Oscillator
  • RVLV 29.92
  • PTGX 34.89

About RVLV Revolve Group Inc.

The Revolve Group is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2023 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the US, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 20% of sales from private-label offerings, while focusing on building an inventory of unique products from emerging fashion brands with less than $10 million in annual sales.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: